Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$2.85 - $3.73 $130,145 - $170,330
-45,665 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$3.24 - $5.18 $147,954 - $236,544
45,665 New
45,665 $154,000
Q3 2021

Nov 15, 2021

SELL
$3.94 - $5.84 $7.34 Million - $10.9 Million
-1,862,200 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$4.26 - $6.5 $1.51 Million - $2.3 Million
354,200 Added 23.49%
1,862,200 $8.16 Million
Q1 2021

May 17, 2021

BUY
$5.03 - $8.8 $4.95 Million - $8.67 Million
984,700 Added 188.17%
1,508,000 $9.37 Million
Q4 2020

Feb 16, 2021

SELL
$4.04 - $5.31 $2.16 Million - $2.84 Million
-534,719 Reduced 50.54%
523,300 $2.56 Million
Q3 2020

Nov 16, 2020

SELL
$3.64 - $7.76 $184,278 - $392,857
-50,626 Reduced 4.57%
1,058,019 $4.45 Million
Q2 2020

Aug 14, 2020

SELL
$4.78 - $8.26 $38.8 Million - $67 Million
-8,108,345 Reduced 87.97%
1,108,645 $7.67 Million
Q1 2020

May 15, 2020

BUY
$4.0 - $21.53 $31 Million - $167 Million
7,744,507 Added 525.95%
9,216,990 $36.9 Million
Q4 2019

Feb 14, 2020

BUY
$13.94 - $24.12 $20.5 Million - $35.5 Million
1,472,483 New
1,472,483 $31.6 Million
Q3 2019

Nov 15, 2019

SELL
$13.89 - $23.16 $61.3 Million - $102 Million
-4,415,364 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$16.27 - $20.51 $5.11 Million - $6.44 Million
314,041 Added 7.66%
4,415,364 $85.6 Million
Q1 2019

May 15, 2019

SELL
$12.61 - $22.33 $30.7 Million - $54.4 Million
-2,437,596 Reduced 37.28%
4,101,323 $85.1 Million
Q4 2018

Feb 14, 2019

BUY
$12.41 - $22.98 $48.8 Million - $90.4 Million
3,933,620 Added 150.99%
6,538,919 $89 Million
Q3 2018

Nov 14, 2018

BUY
$2.45 - $16.27 $6.38 Million - $42.4 Million
2,605,299 New
2,605,299 $42.4 Million
Q1 2018

May 15, 2018

SELL
$2.99 - $4.44 $747,500 - $1.11 Million
-250,000 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$3.06 - $4.09 $765,000 - $1.02 Million
250,000
250,000 $1 Million

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $282M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.